Gaby Inc Announces Engagement with Veteran Firm Hybrid Financial Ltd., to Help Get the GABY Story Out to New Investors and Interested Parties
GABY Inc. has retained Hybrid Financial Ltd. to boost investor engagement following its recent upgrade to the OTCQB under the ticker GABLF. This partnership aims to connect with financial professionals across North America, enhancing visibility for U.S. investors. GABY reported a record Q2 revenue of $11.3 million and a 35% gross profit margin, alongside accolades including recognition in Inc. Magazine's list of fastest-growing companies. GABY focuses on cannabis retail and operates Mankind Dispensary in California.
- Record Q2 revenue of $11.3 million.
- Gross profit margin of 35%.
- Inclusion in Inc. Magazine's list of fastest-growing companies.
- None.
The engagement comes as GABY's recent upgraded OTC listing increases the company's visibility for U.S. investors under the ticker GABLF
SANTA DIEGO, CA / ACCESSWIRE / September 20, 2021 / GABY Inc. ("GABY" or the "Company") (CSE:GABY)(OTCQB:GABLF), a California consolidator of cannabis dispensaries and the parent company of San Diego's Mankind Dispensary ("Mankind"), announces it has retained Hybrid Financial Ltd. ("Hybrid Financial").
Hybrid Financial connects issuers to the investment community across North America using a data driven approach. Through this retainer, GABY will engage in an immediate campaign to directly interface with financial professionals across North America.
The announcement follows a recent string of positive accolades and achievements, including record Q2 revenue of
"I'm pleased to be engaging the services of Hybrid Financial," said Margot Micallef, Founder, and CEO of GABY Inc. "This partnership will help get the GABY story out to a wider audience. This, in conjunction with our recent upgrade to the OTCQB, increases our visibility to U.S. and Canadian investors attracted by GABY's growth, highly experienced management team and recent financial milestones and successes.".
About GABY Inc.
GABY Inc. is a California-focused retail consolidator and the owner of Mankind Dispensary, one of the oldest licensed dispensaries in California. Mankind is a well-known, and highly respected dispensary with deep roots in the California cannabis community operating in San Diego, California. GABY curates and sells a diverse portfolio of products, including its own proprietary brands, Lulu's™ and Kind Republic™ through Mankind, manufactures Kind Republic, and distributes all its proprietary brands through its wholly owned subsidiary, Wild West Industries Inc.. A pioneer in the industry with a multi-vertical retail foundation, and a strong management team with experience in retail, consolidation, and cannabis, GABY is poised to grow its retail operations both organically and through acquisition.
GABY's shares trade on the Canadian Securities Exchange ("CSE") under the symbol "GABY" and on the OTCQB under the symbol "GABLF". For more information on GABY, visit GABYInc.com
About Hybrid Financial Ltd.:
Hybrid Financial connects issuers to the investment community across North America. Using a data driven approach, Hybrid Financial provides its clients with comprehensive coverage of both American and Canadian markets. Hybrid Financial has offices in Toronto and Montreal. Hybrid Financial is not promoting the specific purchase or sale of securities. It provides its database, technology, and call center services to enable the issuer to disseminate its information to Financial Professionals.
Media Contact:
Senior Communications Manager
Charlie Rohlfs
(631)579-0858
charlie@gabyinc.com
General
Margot Micallef, Founder & CEO
or Investor Relations at IR@GABYinc.com or 800-674-2239
Disclaimer and Forward-Looking Information
The CSE does not accept responsibility for the adequacy or accuracy of this release. Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, certain of which are beyond the control of the Company. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements include, but are not limited to, the Company's anticipated benefits from its engagement with Hybrid Financial. Although GABY believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because GABY can give no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed. Without limitation, these risks and uncertainties include: the severity of the COVID-19 pandemic; risks associated with the cannabis industry in general; failure to benefit from partnerships or successfully integrate acquisitions; actions and initiatives of federal, state and provincial governments and changes to government policies and the execution and impact of these actions, initiatives and policies; the size of the medical-use and adult-use cannabis market; competition from other industry participants; adverse U.S., Canadian and global economic conditions; failure to comply with certain regulations; and departure of key management personnel or inability to attract and retain talent. GABY undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
Each of Mankind and Wild West Industries, are subsidiaries of GABY and hold a cannabis license in the State of California. Readers are cautioned that unlike in Canada which has Federal 032320-F legislation uniformly governing the cultivation, distribution, sale and possession of medical cannabis under the Cannabis Act (Federal), in the United States ("U.S."), cannabis is largely regulated at the State level. Cannabis is legal in the State of California; however, cannabis remains illegal under U.S. federal laws. Notwithstanding the permissive regulatory environment of cannabis at the State level, cannabis continues to be categorized as a controlled substance under the Controlled Substances Act in the U.S. and as such, cannabis-related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. To the knowledge of the Company, the businesses operated by each of GABY's subsidiaries are conducted in a manner consistent with the State law of California, as applicable, and are in compliance with regulatory and licensing requirements applicable in the State of California, respectively. However, readers should be aware that strict compliance with State laws with respect to cannabis will neither absolve GABY, or its subsidiary of liability under U.S. federal law, nor will it provide a defense to any federal proceeding in the U.S. which could be brought against any of GABY, or its subsidiary. Any such proceedings brought against GABY, or its subsidiary may materially adversely affect the Company's operations and financial performance generally in the U.S. market specifically.
SOURCE: GABY Inc.
View source version on accesswire.com:
https://www.accesswire.com/664701/Gaby-Inc-Announces-Engagement-with-Veteran-Firm-Hybrid-Financial-Ltd-to-Help-Get-the-GABY-Story-Out-to-New-Investors-and-Interested-Parties
FAQ
What is GABY Inc.'s recent financial performance?
When did GABY Inc. upgrade its OTC listing?
What is the ticker symbol for GABY Inc. on the OTC market?
Who has GABY Inc. partnered with for investor outreach?
